Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Puetz

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Missouri Medicine|June 10, 2024
Hemophilia Gene Therapy: Another Blessing or Another Curse?John Puetz
Frontiers in Medicine|November 29, 2023
Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virusJohn Puetz
Drug Design, Development and Therapy|August 7, 2010
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patientsJohn Puetz
Journal of Thrombosis and Haemostasis : JTH|March 23, 2025
Factor activity levels and bleeding scores in hemophilia carriers: apparent paradoxesJohn Puetz
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 29, 2021
Descriptive analysis of bleeding symptoms in haemophilia carriers enrolled in the ATHNdatasetJohn Puetz, Dunlei Cheng
Pediatric Blood & Cancer|August 28, 2023
Factor activity levels and bleeding scores in pediatric hemophilia carriers enrolled in the ATHNdatasetJohn Puetz, Brian Hu
Journal of Pediatric Hematology/Oncology|June 16, 2005
Platelet function disorder in Gardner-Diamond syndrome: a case report and review of the literatureJohn Puetz, Timothy Fete
Pediatric Blood & Cancer|December 13, 2017
Normal aPTT in children with mild factor XI deficiencyJohn Puetz, Christopher Hugge, Karen Moser
Pediatric Blood & Cancer|July 22, 2009
Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasmaJohn Puetz, Ginger Darling, Petr Brabec, et al.
The Journal of Pediatrics|September 20, 2011
Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effectJohn Puetz, Char Witmer, Yuan-Shung V Huang, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Missouri Medicine|June 10, 2024
Hemophilia Gene Therapy: Another Blessing or Another Curse?John Puetz
Frontiers in Medicine|November 29, 2023
Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virusJohn Puetz
Drug Design, Development and Therapy|August 7, 2010
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patientsJohn Puetz
Journal of Thrombosis and Haemostasis : JTH|March 23, 2025
Factor activity levels and bleeding scores in hemophilia carriers: apparent paradoxesJohn Puetz
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 29, 2021
Descriptive analysis of bleeding symptoms in haemophilia carriers enrolled in the ATHNdatasetJohn Puetz, Dunlei Cheng
Pediatric Blood & Cancer|August 28, 2023
Factor activity levels and bleeding scores in pediatric hemophilia carriers enrolled in the ATHNdatasetJohn Puetz, Brian Hu
Journal of Pediatric Hematology/Oncology|June 16, 2005
Platelet function disorder in Gardner-Diamond syndrome: a case report and review of the literatureJohn Puetz, Timothy Fete
Pediatric Blood & Cancer|December 13, 2017
Normal aPTT in children with mild factor XI deficiencyJohn Puetz, Christopher Hugge, Karen Moser
Pediatric Blood & Cancer|July 22, 2009
Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasmaJohn Puetz, Ginger Darling, Petr Brabec, et al.
The Journal of Pediatrics|September 20, 2011
Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effectJohn Puetz, Char Witmer, Yuan-Shung V Huang, et al.
Pageof 2